Download an Investor Presentation & Receive Corporate Updates

Medical Cannabis, Modern Science.

XPhyto Therapeutics Corp. is a science focused cannabis company developing analytical testing, processing, and formulation capability through strategic alliances in Canada. XPhyto’s wholly-owned German subsidiary adds European research, cultivation, import, distribution, and manufacturing opportunities. 

Currently holds a unique scientific cannabis cultivation and extraction licence for cannabis-related research and development.

XPhyto in Germany

Canadian Alliances

3rd party testing for licensed producers, wholesalers, distributors and law enforcement.

Clinical Research

Modern research for major health indications, production of pharmaceutical-grade cannabis, and development of proprietary formulas.

World Class Talent

Two strategic collaborations with University of Alberta's faculty of Pharmacy and Pharmaceutical Sciences.